{"DataElement":{"publicId":"7847813","version":"1","preferredName":"Therapeutic Procedure Defibrotide Administered Agent Therapeutic Procedure Reason","preferredDefinition":"information related to the administration of defibrotide","longName":"DEFIB_TX","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"3648771","version":"1","preferredName":"Therapeutic Procedure Defibrotide Administered","preferredDefinition":"information related to the administration of defibrotide.","longName":"TPDfbtAdm","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"2512834","version":"1","preferredName":"Therapeutic Procedure","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"C49236","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B89860A-B9D6-3798-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-21","endDate":null,"createdBy":"UMLLOADER_AGNIS","dateCreated":"2006-08-21","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3648769","version":"1","preferredName":"Defibrotide Administered","preferredDefinition":"A polydeoxyribonucleotide with antithrombotic, thrombolytic, and fibrinolytic properties.  Defibrotide induces the release of prostaglandin 12 and reduces the expression of adhesion molecules on endothelial cells, thereby interfering with platelet and leukocyte adhesion to the endothelium. (NCI04):The act of having given something (e.g., a medication or test).","longName":"C1064:C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Defibrotide Sodium","conceptCode":"C1064","definition":"A polydeoxyribonucleotide with antithrombotic, thrombolytic, and fibrinolytic properties.  Defibrotide induces the release of prostaglandin 12 and reduces the expression of adhesion molecules on endothelial cells, thereby interfering with platelet and leukocyte adhesion to the endothelium. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D26B1937-0747-FB1B-E040-BB89AD4374D0","latestVersionIndicator":"Yes","beginDate":"2013-01-03","endDate":null,"createdBy":"WONGW","dateCreated":"2013-01-03","modifiedBy":"ONEDATA","dateModified":"2013-01-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D26B1937-0758-FB1B-E040-BB89AD4374D0","latestVersionIndicator":"Yes","beginDate":"2013-01-03","endDate":null,"createdBy":"WONGW","dateCreated":"2013-01-03","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":" Changed from CTEP to COG for by script Thu Jan 2 10:00:57 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7847812","version":"1","preferredName":"Agent Therapeutic Procedure Reason","preferredDefinition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._An explanation of the cause of some phenomenon or action.","longName":"7847812v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Treatment","valueDescription":"Treatment","ValueMeaning":{"publicId":"4266622","version":"1","preferredName":"Treatment","longName":"4266622","preferredDefinition":"Treatment","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F6B7E333-6737-B292-E040-BB89AD432F02","latestVersionIndicator":"Yes","beginDate":"2014-04-10","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2014-04-10","modifiedBy":"TSESU","dateModified":"2022-11-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D22E640C-6CCB-4704-E053-4EBD850A1CAC","beginDate":"2021-12-02","endDate":null,"createdBy":"LEEW","dateCreated":"2021-12-02","modifiedBy":"ONEDATA","dateModified":"2021-12-02","deletedIndicator":"No"},{"value":"Prophylaxis","valueDescription":"Prophylaxis","ValueMeaning":{"publicId":"3049887","version":"1","preferredName":"Prophylaxis","longName":"3049887","preferredDefinition":"Prophylaxis","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"838EEC90-5344-EAD2-E040-BB89AD431680","latestVersionIndicator":"Yes","beginDate":"2010-04-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D22E640C-6CDF-4704-E053-4EBD850A1CAC","beginDate":"2021-12-02","endDate":null,"createdBy":"LEEW","dateCreated":"2021-12-02","modifiedBy":"ONEDATA","dateModified":"2021-12-02","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3260878","version":"1","preferredName":"Concomitant Medication","preferredDefinition":"Concomitant Medication per CDISC CM Definition","longName":"CM","context":"NCIP","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA1591D7-FC76-D679-E040-BB89AD43495D","latestVersionIndicator":"Yes","beginDate":"2011-08-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-08-09","modifiedBy":"DWARZEL","dateModified":"2017-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7847811","version":"1","preferredName":"Agent Therapeutic Procedure Reason","preferredDefinition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.:An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.:An explanation of the cause of some phenomenon or action.","longName":"C1708:C49236:C25638","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Agent","conceptCode":"C1708","definition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D22E640C-6CA5-4704-E053-4EBD850A1CAC","latestVersionIndicator":"Yes","beginDate":"2021-12-02","endDate":null,"createdBy":"LEEW","dateCreated":"2021-12-02","modifiedBy":"ONEDATA","dateModified":"2021-12-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D22E640C-6CB6-4704-E053-4EBD850A1CAC","latestVersionIndicator":"Yes","beginDate":"2021-12-02","endDate":null,"createdBy":"LEEW","dateCreated":"2021-12-02","modifiedBy":"LEEW","dateModified":"2022-01-10","changeDescription":"AAML1831-WL","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Defibrotide:","type":"Preferred Question Text","description":"Defibrotide:","url":null,"context":"COG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D22B95EF-7FA8-56A7-E053-4EBD850AC728","latestVersionIndicator":"Yes","beginDate":"2021-12-02","endDate":null,"createdBy":"LEEW","dateCreated":"2021-12-02","modifiedBy":"LEEW","dateModified":"2022-01-10","changeDescription":"AAML1831 -WL","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}